Oppenheimer & CO Inc Prime Medicine, Inc. Transaction History
Oppenheimer & CO Inc
- $6.42 Billion
- Q3 2024
A detailed history of Oppenheimer & CO Inc transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 17,871 shares of PRME stock, worth $59,867. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,871
Previous 21,031
15.03%
Holding current value
$59,867
Previous $108,000
36.11%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PRME
# of Institutions
124Shares Held
64.7MCall Options Held
324KPut Options Held
64.4K-
Alphabet Inc. Mountain View, CA15.1MShares$50.5 Million3.99% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.66MShares$19 Million0.21% of portfolio
-
Black Rock Inc. New York, NY5.11MShares$17.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$16.4 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$12.8 Million0.01% of portfolio
About Prime Medicine, Inc.
- Ticker PRME
- Shares Outstandng 95,730,200
- Market Cap $321M